{"filing":{"accession_number":"0000950103-26-010195","cik":"0001771910","ticker":"ADCT","company_name":"ADC Therapeutics SA","form":"8-K","filing_date":"2026-07-02","report_date":null,"primary_document":"dp249055_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1771910/000095010326010195/dp249055_8k.htm"},"events":[{"id":15987,"run_id":14262,"accession_number":"0000950103-26-010195","anchor_item_number":"5.02","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses one-time retention awards (cash incentives and RSUs) approved by the Board on June 30, 2026 for three named executive officers: CEO Ameet Mallik ($1,795,500 cash + 675,000 RSUs), CFO Jose Carmona ($541,842 cash + 203,700 RSUs), and CMO Mohamed Zaki ($568,974 cash + 213,900 RSUs). This is a compensatory arrangement disclosure under Item 5.02(e), distinct from an appointment or departure, and the aggregate amounts are material to investors assessing executive compensation and potential retention strategy.","company_name":"ADC Therapeutics SA","ticker":"ADCT","filing_date":"2026-07-02","form":"8-K","submitted_at":null,"items":[{"id":13924,"accession_number":"0000950103-26-010195","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses one-time retention awards (cash incentives and RSUs) approved by the Board on June 30, 2026 for three named executive officers: CEO Ameet Mallik ($1,795,500 cash + 675,000 RSUs), CFO Jose Carmona ($541,842 cash + 203,700 RSUs), and CMO Mohamed Zaki ($568,974 cash + 213,900 RSUs). This is a compensatory arrangement disclosure under Item 5.02(e), distinct from an appointment or departure, and the aggregate amounts are material to investors assessing executive compensation and potential retention strategy.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-02T21:08:36.225902+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":13924,"accession_number":"0000950103-26-010195","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses one-time retention awards (cash incentives and RSUs) approved by the Board on June 30, 2026 for three named executive officers: CEO Ameet Mallik ($1,795,500 cash + 675,000 RSUs), CFO Jose Carmona ($541,842 cash + 203,700 RSUs), and CMO Mohamed Zaki ($568,974 cash + 213,900 RSUs). This is a compensatory arrangement disclosure under Item 5.02(e), distinct from an appointment or departure, and the aggregate amounts are material to investors assessing executive compensation and potential retention strategy.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-02T21:08:36.225902+00:00","company_name":"ADC Therapeutics SA","ticker":"ADCT","filing_date":"2026-07-02"}]}